Bio-Techne Corp. Stock Rises Tuesday, Still Underperforms Market
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Bio-Techne, Waters Strike Co-Marketing, Co-Promotion Deal
Express News | Bio-Techne Announces Biotherapeutic Characterization Strategic Co-Marketing and Co-Promotion Agreement
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
Press Release: ScaleReady Awards a G-Rex(R) Grant to Moonlight Bio
What You Can Learn From Bio-Techne Corporation's (NASDAQ:TECH) P/S
Bio-Techne and MedSanTek Team Up to Boost Research in Turkey and Azerbaijan
Express News | Bio-Techne Announces New Distribution Agreement With Medsantek to Expand Access to Portfolio Across Turkey
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
S&P 500 Futures Rise In Premarket Trading; Bausch + Lomb, Bio-Techne Lag
RBC Capital Sticks to Their Hold Rating for Bio-Techne (TECH)
BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
BioCytics Awarded a G-Rex Grant From ScaleReady
Gene Editing Market Forecast Report 2024, With Profiles of Merck, GenScript, Revvity, Lonza, Precision BioSciences, Cellectis, AMSBIO, Synthego, Takara Bio, Bio-Techne, Reprocell and More
BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
Express News | Gemini Bioproducts: Transition of FBS Products to Geminibio Effective December 3, 2024
Express News | Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory From Bio-Techne
Press Release: Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory From Bio-Techne
OverT Bio Receives $120K G-Rex Grant to Propel Solid Tumor Cell Therapy Advancements